Tag: Pharnext
Pharnext: Postponement of the extraordinary general meeting of shareholders of February 11, 2022 – 02/10/2022 at 7:30 p.m.
PARIS, France, February 10, 2022 at 7:30 p.m. (CET) – Pharnext SA (FR0011191287 – ALPHA) (“the Company”), a late-stage biopharmaceutical company, pioneering a new approach to developing innovative drug combinations…
Pharnext: issues a tranche of 350 convertible bonds – 01/25/2022 at 6:20 p.m.
(CercleFinance.com) – Pharnext announces this evening that it has issued a seventh tranche of 350 bonds convertible into shares (OCA) with a nominal value of 10,000 euros each, under a…
Pharnext: draws a tranche of 350 convertible bonds
(CercleFinance.com) – Pharnext announces this evening that it has issued a seventh tranche of 350 bonds convertible into shares (OCA) with a nominal value of 10,000 euros each, under a…
Pharnext and Global Tech Opportunities 13 have entered into an agreement providing for the cessation of financing by means of convertible bonds from the end of May 2022 – 12/22/2021 at 7:30 p.m.
PARIS, France, December 22, 2021 at 7:30 p.m. (CET) – Pharnext SA (FR0011191287 – ALPHA) (The “Company”), an advanced clinical biopharmaceutical company pioneering a new approach to the development of…